Kura Oncology (NASDAQ:KURA) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $32.00 target price on the stock. A number of other equities analysts also recently commented on the company. JMP Securities increased their price objective on Kura Oncology […]

Related Keywords

Switzerland ,United States ,Swiss ,Troy Edward Wilson ,Thomas James Doyle ,Nasdaq ,York Mellon Corp ,Jupiter Asset Management Ltd ,Franklin Resources Inc ,Charles Schwab Investment Management Inc ,Swiss National Bank ,Kura Oncology Inc ,Kura Oncology ,Free Report ,Moderate Buy ,Get Free Report ,Edward Wilson ,James Doyle ,New York Mellon Corp ,Schwab Investment Management ,Asset Management ,National Bank ,Lysinek Specific Methyltransferase ,Kura Oncology Daily ,